Skip to main content
Clinical Trials/NCT03026192
NCT03026192
Terminated
Not Applicable

Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment

Albany Medical College1 site in 1 country4 target enrollmentDecember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patent Ductus Arteriosus
Sponsor
Albany Medical College
Enrollment
4
Locations
1
Primary Endpoint
Change in NIRS readings
Status
Terminated
Last Updated
7 years ago

Overview

Brief Summary

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
June 30, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kate Tauber

Assistant Professor

Albany Medical College

Eligibility Criteria

Inclusion Criteria

  • preterm infants less than 32 weeks gestation

Exclusion Criteria

  • infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.

Outcomes

Primary Outcomes

Change in NIRS readings

Time Frame: 3 days

Study Sites (1)

Loading locations...

Similar Trials